Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21cfb7dd79973529725cde19b4f43cba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_949a704508f5330979e358cb6e69478a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
filingDate |
1997-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b573c1c11394e739106ffeb28c9b39b |
publicationDate |
1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9809634-A1 |
titleOfInvention |
Nad or nadp containing pharmaceutical compositions for treating aids |
abstract |
A pharmaceutical composition for treatment of acquired immunodeficiency syndrome comprising a coenzyme selected from amongst NAD and NADP and at least one pharmaceutically acceptable inactive ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012017367-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8852582-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI20101459-A1 |
priorityDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |